PRECURSOR B-LYMPHOBLASTIC LYMPHOMA RECURRENT

This adverse event was reported 28 times

PRECURSOR B-LYMPHOBLASTIC LYMPHOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BLINATUMOMAB 15 0.0014
1 INOTUZUMAB OZOGAMICIN 2 0.0007
2 NICARDIPINE HYDROCHLORIDE 1 0.0004
3 CLOFARABINE 1 0.0004
4 FOSCARNET SODIUM 1 0.0002
5 NICARDIPINE 1 0.0002
6 PEGASPARGASE 2 0.0002
7 MITOXANTRONE HYDROCHLORIDE 1 0.0002
8 FLUDARABINE PHOSPHATE 6 0.0002
9 TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM 1 0.0001
See all drugs enriched for association with PRECURSOR B-LYMPHOBLASTIC LYMPHOMA RECURRENT